Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Diasorin SpA's Enterprise Value is €3,934 Mil.
Diasorin SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €215 Mil. Therefore, Diasorin SpA's EV-to-EBIT ratio for today is 18.27.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Diasorin SpA's Enterprise Value is €3,934 Mil.
Diasorin SpA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €344 Mil. Therefore, Diasorin SpA's EV-to-EBITDA ratio for today is 11.45.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Diasorin SpA's Enterprise Value is €3,934 Mil.
Diasorin SpA's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €1,168 Mil. Therefore, Diasorin SpA's EV-to-Revenue ratio for today is 3.37.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Diasorin SpA's Enterprise Value is €3,934 Mil.
Diasorin SpA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €330 Mil. Therefore, Diasorin SpA's EV-to-FCF ratio for today is 11.93.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Diasorin SpA (MIL:DIA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Diasorin SpA's current Enterprise Value is €3,934 Mil.
Diasorin SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €215 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Diasorin SpA's current Enterprise Value is €3,934 Mil.
Diasorin SpA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €344 Mil.
Diasorin SpA's current Enterprise Value is €3,934 Mil.
Diasorin SpA's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,168 Mil.
Diasorin SpA's current Enterprise Value is €3,934 Mil.
Diasorin SpA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €330 Mil.
Diasorin SpA's current Enterprise Value is €3,934 Mil.
Diasorin SpA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €330 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diasorin SpA Enterprise Value Related Terms
Diasorin SpA Enterprise Value Historical Data
* Premium members only.
The historical data trend for Diasorin SpA's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:DIA vs TMO, DHR, IDXX: Enterprise Value Comparison
For the Diagnostics & Research subindustry, Diasorin SpA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diasorin SpA Enterprise Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Diasorin SpA's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Diasorin SpA's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diasorin SpA (MIL:DIA) has a Enterprise Value of €3,934 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Diasorin SpA and its competitors.
Is Diasorin SpA's Enterprise Value too high?
Diasorin SpA's current Enterprise Value is €3,934 Mil. Overall, Diasorin SpA has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diasorin SpA's Enterprise Value compare to TMO and DHR?
Diasorin SpA's Enterprise Value of €3,934 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Diasorin SpA and its competitors. Diasorin SpA's current Enterprise Value is €3,934 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diasorin SpA stock overvalued right now?
Based on GuruFocus' analysis, Diasorin SpA (MIL:DIA) is currently considered Modestly Undervalued. The stock's GF Value™ is €90.16, compared to a current price of €67.76 — trading 24.8% below its estimated fair value. The current Enterprise Value is €3,934 Mil. Diasorin SpA's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Diasorin SpA (MIL:DIA), the current Enterprise Value is €3,934 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diasorin SpA (MIL:DIA) Overvalued in 2026?
Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued.
The current stock price of €67.76 is trading 24.8% below its estimated GF Value™ of €90.16.
GuruFocus considers Diasorin SpA to be Modestly Undervalued.
Key valuation signals for MIL:DIA:
Enterprise Value: €3,934 Mil
GF Value™: €90.16 vs. price of €67.76 (24.8% below fair value)
No single metric tells the full story. See the MIL:DIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
69GF Score
Get the complete analysis for MIL:DIA
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:DIA has been successfully added to your 
